Department creates environment for entrepreneurial activity that fuels advances in artificial intelligence, cancer prediction and patient safety.

In a new paper, Keshav Singh, Ph.D., outlines the case for the “powerhouse of the cell” as a hideout and unwitting ally for SARS-CoV-2.

Researchers from UAB’s Precision Medicine Institute have used AI to identify hundreds of potential treatments, which are now being tested through the COVID-19 research fund that the institute helped launch.

New microbiology faculty member Nicholas Lennemann is transforming the fluorescent virus assay he developed into a new tool against coronavirus in work supported through UAB’s urgent COVID-19 research fund.

Bioreactors built to offer new insights on lung cancer are being adapted to study coronavirus infection and test new treatments in this project supported through UAB’s urgent COVID-19 research fund.

Virologist Kevin Harrod, Ph.D., is the institution’s resident expert on SARS viruses. His lab is handling biological validation for innovative drug-repurposing studies supported by the School of Medicine’s Urgent COVID-19 research fund.

Microbiologists Troy Randall and Frances Lund are building key proteins from several coronaviruses to study antibody cross-reactivity and other crucial questions in this project supported through UAB’s urgent COVID-19 research fund.

In this project supported through UAB’s urgent COVID-19 research fund, Professor Randall Davis aims to identify antibodies that block SARS-CoV-2 from entering human cells — information that could guide convalescent plasma therapy and more.

Protecting workers’ vision has become more challenging as a diverse workforce stretches the definition of a “typical” face. UAB researchers are going 3D to keep employees safe.

In this project supported through UAB’s urgent COVID-19 research fund, Assistant Professor Benjamin Larimer, Ph.D., adapts his lab’s work on phage display — normally used to identify new cancer treatments — to overcome limitations of antibody and vaccine testing.

Researchers in the School of Public Health illustrate how tweets labeling the novel coronavirus as the “Chinese virus” exploded across the United States.

Trial to rapidly identify and treat the immune overreaction that may be behind some cases of severe COVID-19 is made possible through UAB Medicine’s Urgent COVID-19 Clinical Research and Laboratory Research Fund.

Educating new primary care physicians about effective treatments for opioid use disorder in partnership with Cahaba Medical Care.

Just in time to tackle COVID-19, the Informatics Institute launches a bigger, more capable version of its team-science data platform.

Lab-grown human heart tissue could mean better drug tests, faster transplants and more accurate models of disease. To get there, Palaniappan Sethu, Ph.D., is stretching ingenuity.

UAB algorithm offers doctors a step-by-step guide to connect patients with HIV to best smoking-cessation options.

Ariann Nassel in the Lister Hill Center for Health Policy works with UAB researchers to reveal patterns in patient care, neighborhood features, dental practices and more.

New UAB research is combining mathematical modeling and advanced imaging to find the right mix of therapy for patients with a common subtype of breast cancer.

Are there differences in the way that minority groups and people with low socioeconomic status experience chronic low back pain? Learn more about an ongoing study in this new series that looks behind the scenes of UAB’s latest grants and contracts.

Learn how UAB researchers are taking on the most feared complication of the new generation of blood-thinning drugs. 

An innovative grant aims to speed up antiretroviral therapy initiation for patients in the Deep South newly diagnosed with HIV.

UAB-led study finds that genetic variations associated with cognitive decline after BMT identify high-risk patients more accurately than current methods.

Go behind the scenes of UAB’s latest grants and contracts in this new series to discover a fresh approach to treat an autoimmune disease and its mysterious double-negative B cells.

Go behind the scenes of our latest grants and contracts in this new series — including a grant that is taking UAB investigators into the heart of the dark web of opioid trafficking.  

New research funding powers UAB investigators pushing the envelope in all areas of discovery. Go behind the scenes of our latest grants and contracts in this new series — including a peek inside an orbiting super-fridge that sips electricity in space.  

Diet and lifestyle choices fuel inflammation, which in turn contribute to heart disease, cancer and more, according to Suzanne Judd, Ph.D., and colleagues, who created a new way to quantify the effects of 19 foods and four lifestyle elements. See how your routine adds up.

In her lab, “gray-hair lady” Melissa Harris, Ph.D., assistant professor of biology, is working on bringing pigment cells back from the dead.

Investigators attract major grants to use AI on failed drug trials, cell-free DNA and puzzling CT scans.

Do you speak APT1A3? To help patients with mysterious conditions, these precision pioneers are seeking expertise in targeted genes.

Single-cell sequencing enables researchers to study disease as never before — even skipping through time to follow crucial populations. UAB experts explain what all the fuss is about and how to get started in single-cell research — a field that is wide open for discovery.

Biology postdoc Jessica Hoffman earns a career-launching NIH K99/R00 award with her intriguing research into size and lifespan in dogs and other species.

UAB researcher David Vance, Ph.D., has helped prove that boosting cognitive reserve can protect your brain as it ages. Here’s how you can leverage your UAB benefits to make it happen.

Neurobiologist Summer Thyme, Ph.D., has built her own devices and software to leverage zebrafish models that shed light on genes associated with human schizophrenia.

Biostatistician Charity Morgan, Ph.D., delves into esoteric equations to advance research in the age of precision medicine.

An experimental PET scan developed by new radiology faculty member Ben Larimer, Ph.D., captures T cells in the act of destroying tumors. A first-in-humans clinical trial is set to start at UAB this fall.

Two past Expo presenters explain what students have to gain from UAB’s undergraduate research showcase. Abstract submissions are open now through Nov. 18.

Noha Sharafeldin, MBBCh, Ph.D., of the Institute for Cancer Outcomes and Survivorship, used UAB’s supercomputer to identify biomarkers linked with cognitive impairment in patients who received a blood or marrow transplant. She’s also testing a way to repair the damage.

Faculty at UAB developed Rigor, Reproducibility and Transparency to draw attention to common lab mistakes. The gamified online course has spread to 15 insitutions and counting.

For the past six years, pathology Professor Upender Manne, Ph.D., has provided students a chance for a summer of “total immersion” in research as part of a major, multi-pronged effort to tackle the profound cancer disparities seen in African-American populations and build a cancer-fighting pipeline.

Submissions are being accepted through Sept. 1.